Table 2.

Examples of clinical trials done on the roles of lncRNAs as biomarkers or in treatment agents.

Status of the clinical trials	Objectives	Condition of the disease	Clinical trial Identifier
Completed	Study the sensitivity and specificity of serum exosome non-coding RNA as a lung cancer biomarker	Lung Cancer	NCT03830619
Recruiting	Researchers examined the relationship between lncRNA H19 and Insulin-Like Growth Factor 1 Receptor (IGF-1R) mRNA gene expressions in lymph nodes from HCC and T2DM patients to test whether there may be a pathophysiological link between these two diseases that may become a therapeutic target for both.	Hepatocellular Carcinoma Type 2 Diabetes Cancer	NCT04767750
Not yet Recruiting	Evaluate the clinical utility of detecting lncRNA CCAT1 expression in the diagnosis of colorectal cancer patients & its relation to tumor staging	Glioma, Glioblastoma Multiforme	NCT04269746
Recruiting	Determining the Role of LncRNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma	Hepatocellular Carcinoma, Liver, Cirrhosis, Diagnoses Disease.	NCT05088811